Patents by Inventor Sijie Wang

Sijie Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12234617
    Abstract: The provided is a construction method for a flood storage area ecological wetland oriented to multi-target collaborative promotion. The construction method includes: I. carrying out ecological wetland construction on a flood storage area by taking promotion of agricultural production as a goal; II. according to a water purification target of the flood storage area of the ecological wetland and a current pollution condition in the flood storage area, constructing the ecological wetland based on improvement of the water purification target when the flood storage area does not reach the water purification target at present; and III, in order to improve the biodiversity, carrying out the following ecological wetland construction on the flood storage area. In the method, agricultural production, water purification and biodiversity improvement of the flood storage area are comprehensively considered. The method is the most effective way for multi-target collaborative promotion of the flood storage area.
    Type: Grant
    Filed: August 22, 2024
    Date of Patent: February 25, 2025
    Assignees: ANHUI SURVEY & DESIGN INSTITUTE OF WATER RESOURCES & HYDROPOWER CO., LTD., CHANGJIANG WATER RESOURCES PROTECTION INSTITUTE
    Inventors: Zhiyuan Cheng, Bo Jiang, Tao Li, Fengchan Zhang, Ting Yu, Xiaoyuan Wang, Zhenxin Li, Santao Xie, Siji Wang, Junfeng Li, Xinyi Zhang
  • Patent number: 12162955
    Abstract: The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.
    Type: Grant
    Filed: January 31, 2023
    Date of Patent: December 10, 2024
    Assignee: Purdue Research Foundation
    Inventors: Casey J. Krusemark, Emily C. Dykhuizen, Sijie Wang
  • Publication number: 20230257421
    Abstract: The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.
    Type: Application
    Filed: January 31, 2023
    Publication date: August 17, 2023
    Inventors: Casey J. Krusemark, Emily C. Dykhuizen, Sijie Wang
  • Patent number: 11566046
    Abstract: The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: January 31, 2023
    Assignee: Purdue Research Foundation
    Inventors: Casey J. Krusemark, Emily C. Dykhuizen, Sijie Wang
  • Publication number: 20210284691
    Abstract: The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.
    Type: Application
    Filed: May 18, 2021
    Publication date: September 16, 2021
    Applicant: Purdue Research Foundation
    Inventors: Casey J Krusemark, Emily C Dykhuizen, Sijie Wang
  • Publication number: 20200385424
    Abstract: The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 10, 2020
    Applicant: Purdue Research Foundation
    Inventors: Casey J. Krusemark, Emily C. Dykhuizen, Sijie Wang